- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł573.6m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł31.25
7D
2.1%
1Y
8.5%
Ryvu Therapeutics
Market Cap: zł353.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł15.30
7D
9.3%
1Y
-52.1%
Molecure
Market Cap: zł119.9m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.82
7D
8.2%
1Y
-2.7%
Poltreg
Market Cap: zł110.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.75
7D
0%
1Y
-41.4%